Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| FSD Pharma Inc | HUGE | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.4592 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.4592 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.4184 - 1.6799 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.4592 | USD |
FSD Pharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 17.71M | 38.50M | - | 0 | -23.61M | -0.61 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
FSD Pharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HUGE Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.4413 | 0.5425 | 0.4413 | 0.477045 | 246,803 | 0.0179 | 4.06% |
| 1 Month | 0.71 | 0.721 | 0.4184 | 0.5298489 | 140,632 | -0.2508 | -35.32% |
| 3 Months | 0.86 | 1.09 | 0.4184 | 0.7298603 | 162,873 | -0.4008 | -46.60% |
| 6 Months | 1.06 | 1.50 | 0.4184 | 0.8898159 | 133,249 | -0.6008 | -56.68% |
| 1 Year | 1.55 | 1.6799 | 0.4184 | 1.11 | 135,455 | -1.09 | -70.37% |
| 3 Years | 1.6296 | 2.25 | 0.4184 | 1.36 | 178,656 | -1.17 | -71.82% |
| 5 Years | 8.0497 | 14.00 | 0.4184 | 2.37 | 478,789 | -7.59 | -94.30% |
FSD Pharma Description
| FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative and inflammatory disorders. The three licensed drug candidates are LUCID-MS, a new chemical entity targeting multiple sclerosis, LUCID-PSYCH, a psychoactive molecule targeting major depressive disorder, and FSD-PEA, an ultra-micronized palmitoyl ethylamine with a favorable safety profile targeting inflammation. |
